CardioGen 20mg Peptides
Precision matters—this vial is prepared for researchers who require consistent, dependable peptide performance.
CardioGen is presented as a peptide lyophilized vial in a stable, dry powder format, built for laboratory workflows that demand clarity and control. This bioregulator peptide arrives as a clean, freeze-dried matrix designed for controlled reconstitution and method development, with a total strength of 20mg per vial. Produced and handled by a USA-based team focused on rigorous standards, CardioGen supports careful investigation across in vitro models where reproducibility and traceability are essential.
- Each vial contains 20mg of CardioGen, enabling reproducible exploration of peptide bioregulation, tissue-focused signaling, and cellular response dynamics in vitro under well-defined laboratory conditions.
As a non-edible research material, the experience is defined by workflow reliability rather than taste or aroma. The lyophilized cake offers a uniform appearance for straightforward handling, facilitating precise weighing and controlled reconstitution by qualified personnel according to institutional protocols. Researchers can expect a disciplined, laboratory-ready presentation intended to minimize variability from vial to vial, supporting consistent assay setup, optimization, and data collection.
Peptide Scientific Labs operates with an emphasis on purity, consistency, and transparency. CardioGen is prepared in a controlled environment with stringent quality oversight and batch-level testing to verify identity and assess purity. Each lot is traceable, with documentation available to support internal review and compliance needs. This material is intended strictly for laboratory research use only—not for human consumption, clinical use, or veterinary applications. Handle with appropriate personal protective equipment, follow your institution’s safety procedures, and store according to your laboratory’s established guidelines.
From sourcing through final packaging, our focus remains non-negotiable: dependable compounds, measured presentation, and clear documentation. CardioGen 20mg reflects that commitment—providing a professional, research-first peptide option for teams advancing careful, methodical inquiry.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is CardioGen typically studied for?
Researchers usually discuss CardioGen in the context of cardiac-cell signaling, myocardial tissue support, and age-related changes in cardiovascular models. A careful FAQ should avoid treatment claims and instead focus on the fact that it is investigated for tissue-specific signaling in preclinical or exploratory research.
What is CardioGen?
CardioGen is generally described as a peptide bioregulator associated with cardiac-tissue research. It belongs to the short-peptide bioregulator family rather than the larger class of growth-hormone secretagogues or incretin analogs. Because naming and sourcing can vary by supplier, it is best described conservatively as a research-use cardiac peptide complex.
What is the Khavinson peptide theory?
The Khavinson peptide theory refers to the body of work developed by Russian researcher Vladimir Khavinson and colleagues starting in the 1970s. The central idea is that short peptides — isolated from specific tissues — can act as tissue-specific bioregulators, binding directly to DNA and modulating gene expression in a way that is selective for the tissue from which they were derived.
This theory forms the scientific background for the bioregulator category of peptides, including compounds such as Epitalon, Thymalin, Prostamax, and Cartalax. The underlying mechanisms continue to be a subject of research, and all compounds listed under this category are offered for laboratory investigation only.
What are peptide bioregulators?
Peptide bioregulators are a class of short peptides — typically di-, tri-, or tetrapeptides — that are studied as tissue-specific signaling molecules. The concept originated in Russian biogerontology research, where extracts of various tissues were fractionated and the active peptide fragments isolated and characterized. Each bioregulator is associated in the research literature with a specific tissue of origin, such as thymus, pineal, prostate, or cartilage.
In research, bioregulators are investigated in the context of gene expression, tissue-specific signaling, and age-related changes in cellular function. All bioregulator products from Peptide Scientific Labs are lyophilized research materials intended solely for in vitro laboratory investigation.
How are bioregulator peptides different from hormones?
Hormones are typically larger molecules — often proteins or steroid compounds — that are secreted by specific endocrine glands and travel through the bloodstream to act on distant target tissues via dedicated receptors. Peptide bioregulators, by contrast, are very short sequences (usually 2 to 4 amino acids) and are studied as intracellular or nuclear-level regulators that interact more directly with chromatin and gene expression in the tissues from which they were originally isolated.
Functionally, hormones tend to coordinate large-scale, system-wide processes, while bioregulators are investigated as fine-grained, tissue-specific modulators. The two categories can overlap in the broader sense of signaling biology, but they are studied as distinct classes of molecules.